± HEALTH The significant advancements in applying artificial intelligence (AI) to healthcare decision-making, medical…− CLIMATE Abstract Deep learning workloads have experienced rapid growth which has resulted in higher energy consumptio…− EDUCATION Generative artificial intelligence (Gen AI) has taken the academic world by storm. This G.I.F.T.S. paper argu…± HEALTH Spontaneous intracerebral hemorrhage (ICH) is a highly lethal and disabling form of stroke, in which hematoma…− HEALTH Aim To explore the notion of post-humanism and the impact of artificial intelligence (AI) on society, nursing…± EDUCATION Aim To examine nursing academics' perceptions and experiences of artificial intelligence (AI) integration in…+ CRIME Riverbank erosion is a catastrophic geomorphological hazard that poses severe ecological and socio-economic c…+ HEALTH Immunotherapy resistance in lung adenocarcinoma (LUAD) remains a critical clinical challenge, and the mechani…
TruaceTracing the truth around AIMonday, August 17, 2026
Subscribe
Health·P Space·Evidence-backed problem·Published 2026-07-12

Accurhythm za420 (pause): FDA malfunction report involving AI

Abstract: The FDA received a malfunction report involving Accurhythm za420 (pause), made by Medtronic, inc.. It was reported that true pause episodes were rejected as false by the artificial intelligence (ai) algorithm. no patient complications have been reported as a result of this event.

TRV-2026-0040Official statisticsPermanent record — cite & verify
Accurhythm za420 (pause): FDA malfunction report involving AI

"4 m old baby after cardiac surgery in HRB clinic" by Bhakua is licensed under CC BY 2.0. To view a copy of this license, visit https://creativecommons.org/licenses/by/2.0/.

The quick read

The FDA received a malfunction report for the Accurhythm za420 (pause) device made by Medtronic, inc. The report stated that the device's artificial intelligence algorithm rejected true pause episodes as false. The source notes that no patient complications have been reported as a result of this event.

If true pauses are misclassified, clinically relevant events could be missed, which matters for monitoring. What remains uncertain is how often this occurs, why the algorithm rejected the episodes, and whether any patients were affected, because the MAUDE entry is a surveillance signal not a verified clinical conclusion.

Main points
  • Device identified as Accurhythm za420 (pause) made by Medtronic, inc.
  • Report is part of FDA MAUDE surveillance data and is described as a signal for follow-up
  • Text explicitly states no patient complications have been reported as a result of this event
Problem

The Accurhythm za420 pause monitor's AI algorithm rejected true pause episodes as false, causing a detection failure

Sources

Reader signal

How should this claim be treated?

The debate